News - Page 241 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article PharmaTher Expands Patent Portfolio with Filing of U.S. Patent for Novel Use of Psilocybin to Treat Cancer

PharmaTher Expands Patent Portfolio with Filing of U.S. Patent for Novel Use of Psilocybin to Treat Cancer

Post published:November 16, 2020
Post category:Press Release

Read more about the article Lobe Sciences Commences Trading Under New Name and Announces Rebranding and Corporate Update

Lobe Sciences Commences Trading Under New Name and Announces Rebranding and Corporate Update

Post published:November 16, 2020
Post category:Press Release

Read more about the article MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities

MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities

Post published:November 16, 2020
Post category:Press Release

Read more about the article Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks

Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks

Post published:November 14, 2020
Post category:Clinical Trials Research

Read more about the article Psychedelic Bulletin: Decrim Ambitions Spread to NJ and CA; Compass Shows Strong Cash Position; Cybin and Entheon Go Public

Psychedelic Bulletin: Decrim Ambitions Spread to NJ and CA; Compass Shows Strong Cash Position; Cybin and Entheon Go Public

Post published:November 13, 2020
Post category:Psychedelic Bulletin

Read more about the article MindMed Announces Q3 2020 Financial Results

MindMed Announces Q3 2020 Financial Results

Post published:November 13, 2020
Post category:Press Release

Read more about the article Silo Wellness Announces the First-of-Its-Kind U.S.-Legal Psychedelic Wellness Nature Retreat in Oregon

Silo Wellness Announces the First-of-Its-Kind U.S.-Legal Psychedelic Wellness Nature Retreat in Oregon

Post published:November 13, 2020
Post category:Press Release

Read more about the article Mind Cure Announces Non-Brokered Private Placement of $3 Million

Mind Cure Announces Non-Brokered Private Placement of $3 Million

Post published:November 13, 2020
Post category:Press Release

Read more about the article European synthetic biology company Octarine raises $1.8M USD in funding and enters pre-clinical studies with novel-improved- cannabinoid and psychedelic derivatives

European synthetic biology company Octarine raises $1.8M USD in funding and enters pre-clinical studies with novel-improved- cannabinoid and psychedelic derivatives

Post published:November 12, 2020
Post category:Press Release

Read more about the article Tryp Appoints Dr. Jim Gilligan, PhD, MBIS, as President and Chief Scientific Officer

Tryp Appoints Dr. Jim Gilligan, PhD, MBIS, as President and Chief Scientific Officer

Post published:November 12, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.